Document Detail


Combined treatment of sudden sensorineural hearing loss with steroid, dextran and piracetam: experience with 68 cases.
MedLine Citation:
PMID:  12937918     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this study was to evaluate the effectiveness of our combined treatment regimen and to clarify the possible prognostic factors in sudden sensorineural hearing loss (SSNHL). In a retrospective chart review, the charts of 68 patients who matched the inclusion criteria of this study were evaluated. All patients were treated with a standard regimen including prednisone, dextran and piracetam between January 1998 and December 2001. Initial (at the beginning of therapy) and final (3 weeks after the beginning of therapy) audiograms were compared with respect to hearing improvement. Possible prognostic factors were also evaluated. Overall hearing improvement was determined as 54.4%. Sex was the only determined prognostic factor in this study. Females had a better prognosis. Our treatment regimen had no superiority to the reported spontaneous hearing recovery. Females seem to have a better prognosis.
Authors:
Erdal Samim; Rahmi Kilic; Ali Ozdek; Hakan Gocmen; Adil Eryilmaz; Ilhan Unlu
Related Documents :
17016718 - Histopathologic indicators of recurrence in meningiomas: correlation with clinical and ...
23397588 - Outcomes after interdisciplinary management of 7 patients with askin tumor.
25129248 - The clinical significance of cdk1 expression in oral squamous cell carcinoma.
19752758 - Prognostic factors according to the treatment schedule in malignant pleural mesothelioma.
16516128 - New agents for the treatment of acute myeloid leukemia.
12212588 - Carcinoma of the nasopharynx: analysis of treatment results in 91 patients.
Publication Detail:
Type:  Journal Article     Date:  2003-08-22
Journal Detail:
Title:  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery     Volume:  261     ISSN:  0937-4477     ISO Abbreviation:  Eur Arch Otorhinolaryngol     Publication Date:  2004 Apr 
Date Detail:
Created Date:  2004-04-22     Completed Date:  2004-09-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9002937     Medline TA:  Eur Arch Otorhinolaryngol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  187-90     Citation Subset:  IM    
Affiliation:
Department of Ear, Nose and Throat, Ministry of Health Research and Training Hospital, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Audiometry
Child
Dextrans / administration & dosage*
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Hearing Loss, Sensorineural / diagnosis,  drug therapy*
Hearing Loss, Sudden / diagnosis,  drug therapy*
Humans
Infusions, Intravenous
Male
Middle Aged
Piracetam / administration & dosage*
Prednisone / administration & dosage*
Probability
Retrospective Studies
Risk Assessment
Severity of Illness Index
Sex Factors
Treatment Outcome
Chemical
Reg. No./Substance:
53-03-2/Prednisone; 7491-74-9/Piracetam; 9004-54-0/Dextrans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multiple system atrophy manifested as dizziness and imbalance: a report of two cases.
Next Document:  Postarthroplasty histiocytic lymphadenopathy in a patient with uterine carcinoma.